Davide Frumento

Davide Frumento worked on type 1 diabetes-related enteropathy (Milan University/Harvard University). He researched adherence to antiretroviral therapy among HIV patients and efficacy of new-generation anti-HCV medications (Genoa University). He explored the delayed onset effects of SIRT6 inhibition in in vitro and in vivo models of Multiple Sclerosis (Genoa University). He investigated anti-influenza and anti-meningococcal vaccination strategies (Genoa University). He worked on Organic Synthesis research, characterizing pyrazolo[3,4-d] pyrimidine tyrosine kinase inhibitors (Genoa University). He is an Adjunct Professor in Epigenetics, researching generational trauma (RomaTre University). Davide is an Adjunct Professor in Organic Chemistry (University of Milan).